We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
H&R Block's (HRB) Q1 Loss Flat Y/Y, Revenues Miss Estimates
Read MoreHide Full Article
H&R Block, Inc. (HRB - Free Report) incurred first-quarter fiscal 2020 loss per share from continuing operations of 72 cents, lower than the Zacks Consensus Estimate of loss of 76 cents.
Loss was flat year over year as increase in pre-tax loss and lower shares outstanding offset increased tax benefit due to favorable discrete items. The company usually incurs loss in the first three quarters of fiscal year due to the seasonality of its tax business.
We observe that shares of H&R Block have gained 5.9% year to date, underperforming the 13% rally of the Zacks S&P 500 composite.
Revenues
Revenues of $150.4 million surpassed the consensus estimate by $1.8 million and increased 3.6% year over year. The improvement was driven by contribution from Wave Financial acquisition, improved tax return volumes in both U.S. Assisted and DIY, and increased international tax preparation fees.
Expenses
Total operating expenses were $345.5 million, up 5.6% year over year. The increase was due to technology and Wave Financial related investments partially offset by lower depreciation and amortization expense.
Financial Position
H&R Block exited the quarter with cash and cash equivalents of $607.7 million compared with $1.6 billion at the end of the prior quarter. Long-term debt was $1.5 billion, flat with the prior quarter figure. The company used $483.8 million of cash in operating activities and capex was $15.2 million.
The company paid out dividends of $52.5 million in the quarter. A cash dividend of 26 cents per share is payable Oct 1, 2019 to shareholders of record on Sep 13, 2019. H&R Block repurchased and retired around 1.6 million shares at an aggregate price of $44.1 million.
Outlook
The company reaffirmed its fiscal 2020 outlook. It continues to expect total revenue growth of 1.5% to 3.5%. EBITDA margin is expected between 24% and 26%. Effective tax rate is anticipated to be 23-25%.
Some better-ranked stocks in the broader Zacks Business Services sector include Fiserv , Booz Allen Hamilton (BAH - Free Report) and Charles River Associates (CRAI - Free Report) , each carrying a Zacks Rank #2 (Buy).
The long-term expected EPS (three to five years) growth rate for Fiserv, Booz Allen and Charles River is 12%, 13% and 13%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
H&R Block's (HRB) Q1 Loss Flat Y/Y, Revenues Miss Estimates
H&R Block, Inc. (HRB - Free Report) incurred first-quarter fiscal 2020 loss per share from continuing operations of 72 cents, lower than the Zacks Consensus Estimate of loss of 76 cents.
Loss was flat year over year as increase in pre-tax loss and lower shares outstanding offset increased tax benefit due to favorable discrete items. The company usually incurs loss in the first three quarters of fiscal year due to the seasonality of its tax business.
We observe that shares of H&R Block have gained 5.9% year to date, underperforming the 13% rally of the Zacks S&P 500 composite.
Revenues
Revenues of $150.4 million surpassed the consensus estimate by $1.8 million and increased 3.6% year over year. The improvement was driven by contribution from Wave Financial acquisition, improved tax return volumes in both U.S. Assisted and DIY, and increased international tax preparation fees.
Expenses
Total operating expenses were $345.5 million, up 5.6% year over year. The increase was due to technology and Wave Financial related investments partially offset by lower depreciation and amortization expense.
Financial Position
H&R Block exited the quarter with cash and cash equivalents of $607.7 million compared with $1.6 billion at the end of the prior quarter. Long-term debt was $1.5 billion, flat with the prior quarter figure. The company used $483.8 million of cash in operating activities and capex was $15.2 million.
The company paid out dividends of $52.5 million in the quarter. A cash dividend of 26 cents per share is payable Oct 1, 2019 to shareholders of record on Sep 13, 2019. H&R Block repurchased and retired around 1.6 million shares at an aggregate price of $44.1 million.
Outlook
The company reaffirmed its fiscal 2020 outlook. It continues to expect total revenue growth of 1.5% to 3.5%. EBITDA margin is expected between 24% and 26%. Effective tax rate is anticipated to be 23-25%.
Zacks Rank and Stocks to Consider
H&R Block currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Some better-ranked stocks in the broader Zacks Business Services sector include Fiserv , Booz Allen Hamilton (BAH - Free Report) and Charles River Associates (CRAI - Free Report) , each carrying a Zacks Rank #2 (Buy).
The long-term expected EPS (three to five years) growth rate for Fiserv, Booz Allen and Charles River is 12%, 13% and 13%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>